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We investigated serotonin signaling in C. elegans as
a paradigm for neural regulation of energy balance
and found that serotonergic regulation of fat is
molecularly distinct from feeding regulation. Seroto-
nergic feeding regulation is mediated by receptors
whose functions are not required for fat regulation.
Serotonergic fat regulation is dependent on a neurally
expressed channel and aG protein-coupled receptor
that initiate signaling cascades that ultimately pro-
mote lipid breakdown at peripheral sites of fat
storage. In turn, intermediates of lipid metabolism
generated in the periphery modulate feeding be-
havior. These findings suggest that, as in mammals,
C. elegans feeding behavior is regulated by extrinsic
and intrinsic cues. Moreover, obesity and thinness
are not solely determined by feeding behavior.
Rather, feeding behavior and fat metabolism are co-
ordinated but independent responses of the nervous
system to the perception of nutrient availability.
INTRODUCTION
To survive, grow, and reproduce, animals must maintain ade-
quate energy reservoirs in environments where food availability
is often scarce and dynamic. In mammals, the nervous system
regulates energy balance through myriad behavioral, physiolog-
ical, and metabolic responses elicited by extrinsic and intrinsic
cues of food availability and energy demand (Morton et al.,
2006). Themolecular underpinnings of these responses and their
coordination remain key challenges in understanding energy
balance and fat regulation.
The neurotransmitter 5-hydroxytryptamine (5-HT, serotonin)
regulates food-related behaviors andphysiology in diverse verte-
brate and invertebrate phyla (Tecott, 2007). A loss-of-function
mutation in the mammalian 5-HT2C receptor leads to obesity
(Tecott et al., 1995), and pharmacological manipulations that in-
crease central nervous system5-HT causeweight loss in rodents
(Edwards and Stevens, 1991; Vickers and Dourish, 2004) and
humans (Sugrue, 1987; Weintraub et al., 1984). Recent efforts
have begun to delineate the molecular mechanisms through
which 5-HT exerts its control on mammalian energy balance
(Heisler et al., 2002, 2003, 2006). However, this is a challenging
task given the complexity of mammalian energy regulatory path-ways, compensatory mechanisms, and roles of both peripheral
and central serotonergic pathways in energy balance (Fernstrom
and Choi, 2008; Lam and Heisler, 2007; Tecott, 2007).
C. elegans provides a tractable system for defining the molec-
ular genetics of fat regulation and food-related behaviors and for
disentangling the complex homeostatic mechanisms that oper-
ate in multiple tissues. Evolutionarily conserved pathways regu-
late food-related behaviors as well as fat regulatory mechanisms
in C. elegans (Ashrafi, 2006; de Bono and Maricq, 2005). For
instance, neuropeptide Y, dopamine, and 5-HT signaling path-
ways modulate food-related behaviors in mammals (Morton
et al., 2006) and C. elegans (de Bono and Bargmann, 1998; Hills
et al., 2004; Sze et al., 2000). Moreover,C. elegans fat reservoirs,
which are stored in intestinal and skin-like epidermal cells
(Ashrafi, 2006; Kimura et al., 1997), are regulated through insulin
and other neuroendocrine and transcriptional regulators of met-
abolic pathways that are also conserved in mammals (McKay
et al., 2003; Ogg et al., 1997; Van Gilst et al., 2005).
We examinedC. elegans serotonergic fat regulation as a para-
digm for elucidating how the nervous system coordinates energy
balance. In the hermaphrodite C. elegans, 5-HT synthesis is lim-
ited to only a few neurons (Sze et al., 2000). Animals deficient in
5-HT biosynthesis are viable but display phenotypes mimicking
responses seen in food-deprived wild-type animals such as
reduced mating and retention of eggs (Loer and Kenyon, 1993;
Sze et al., 2000; Waggoner et al., 1998). Conversely, exoge-
nously supplied 5-HT stimulates egg laying and mating, re-
sponses associated with the re-exposure of food-deprived
animals to food (Horvitz et al., 1982; Loer and Kenyon, 1993).
5-HT signaling is also required for the dramatic reduction of loco-
motionwhen food-deprived animals re-encounter food, ensuring
that these animals spend more time in a food-replete environ-
ment (Sawin et al., 2000). 5-HT signaling also underlies experi-
ence-dependent choices that C. elegans display in selecting
growth-promoting bacteria and in avoiding pathogens (Shtonda
and Avery, 2006; Zhang et al., 2005).
5-HT is a potent modulator of C. elegans feeding rate and fat
content.C. elegans ingest bacteria throughpharyngeal pumping.
Defects in pharyngeal pumping reduce food intake and are as-
sociated with a starved appearance (Avery and Horvitz, 1990).
C. elegans match their feeding rate to food availability: feeding
rate increases with increasing concentrations of food and de-
creases as food concentration diminishes (Avery and Horvitz,
1990). However, the experience of starvation modulates feeding
rate such that animals that have undergone a period of food dep-
rivation temporarily feed faster than well-fed worms (Avery and
Horvitz, 1990). Thus, C. elegans feeding behavior is modulatedCell Metabolism 7, 533–544, June 2008 ª2008 Elsevier Inc. 533
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increased feeding rate even in the absence of food (Avery and
Horvitz, 1990), while tph-1(-) mutants, which fail to synthesize
5-HT, display reduced feeding (Sze et al., 2000). Despite reduced
feeding, tph-1(-)mutants accumulate excess fat (Szeet al., 2000).
Furthermore, we report here that exogenous administration of
5-HT causes potent fat reduction inC. elegansdespite increasing
feeding rate. Thus, similar to mammals, the deficiency and ex-
cess of 5-HT lead to fat accumulation and loss, respectively, in
C.elegans.Unlikemammals, the regulationofC.elegans fat levels
by 5-HT is inversely correlated with 5-HT-induced feeding rates.
Todecipher themolecular relationshipsbetweenvarious5-HT-
regulated responses, we identified molecular determinants of 5-
HT-induced fat reduction.Our findings indicate that inC. elegans,
serotonergic regulation of fat is molecularly dissociated from se-
rotonergic regulation of feeding. We identified both neurally and
peripherally expressed genes that mediate serotonergic fat
reduction, as well as internal homeostatic signals that modulate
feeding rate. Our findings suggest that feeding behavior and fat
metabolism are coordinated but independent responses of the
nervous system to intrinsic and extrinsic cues of nutrient avai-
Figure 1. 5-HT Reduces Fat Content
(A) Images of Nile red-stained wild-type andmod-
5(n3314) animals treated with 5-HT (serotonin) or
fluoxetine. The anterior end of the animals shown
is oriented toward the left.
(B) Quantification of Nile red fluorescence (n = 8
animals per condition). Data are expressed as
a percentage of vehicle-treated animals on OP50
bacteria ± standard error of the mean (SEM).
**p < 0.005 versus vehicle-treated controls or indi-
cated comparisons.
(C) Thin-layer chromatography (TLC) measure-
ment of extracted triacylglycerides (TAG) shows
that 5-HT treatment leads to fat loss. Data are
expressed as the average of triplicate determina-
tions ± SEM. *p < 0.05.
lability. Since several lines of evidence
suggest that 5-HT-induced changes in
feeding alone cannot account for the
observed effects on fat content in mam-
mals (Fernstrom and Choi, 2008), we
speculate that the regulation of fat con-
tent independent of feeding may be the
principal, evolutionarily conserved mech-
anism of serotonergic fat metabolism.
RESULTS
Increased 5-HT Signaling Causes
Fat Reduction in C. elegans
Chronic administration of exogenous
5-HT to wild-type animals decreased fat
content (Figure 1) but increased feeding
rate (Horvitz et al., 1982) (Figure 2A). Re-
duced fat content of 5-HT-treated ani-
mals was visualized by Nile red staining
(Figures 1A and 1B) and confirmed by
thin-layer chromatography (TLC) quantitation of total triglycer-
ides extracted from vehicle- and 5-HT-treatedworms (Figure 1C)
and by Sudan black fat staining (see Figure S1 available online).
5-HT-induced fat decrease was dose dependent and reversible
(Figure 1; Figure S1). The 5 mM 5-HT dose has typically been
used for locomotor, egg-laying, and feeding-rate assays (Demp-
sey et al., 2005; Hobson et al., 2006; Horvitz et al., 1982), and it
is estimated that the effective 5-HT concentration in worms is
approximately 1000-fold below that added to culture plates.
5-HT treatment caused similar fat and feeding responses in
both larval-stage animals and adults (data not shown), indicating
that the observed phenotypes were due to regulatory rather than
developmental processes.
Other manipulations to increase endogenous concentrations
of synaptic 5-HT also reduced fat content. Administration of flu-
oxetine, a 5-HT-specific reuptake inhibitor (Messing et al., 1975),
elicited fat reduction similar in magnitude to exogenous 5-HT
treatment (Figure 1), while animals deficient in mod-5, a 5-HT
reuptake transporter (Ranganathan et al., 2001), displayed
reduced fat levels relative to wild-type animals (Figure 1). While
mod-5(n3314) mutants were further susceptible to the534 Cell Metabolism 7, 533–544, June 2008 ª2008 Elsevier Inc.
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tent with previous identification of MOD-5 as a target of fluoxe-
tine (Ranganathan et al., 2001), these animals were resistant to
further fat reduction by fluoxetine treatment (Figures 1A and
1B). Thus, despite increasing feeding rate, excess 5-HT signaling
from exogenous and endogenous sources reduces fat content.
Distinct Receptors Mediate Serotonergic Regulation
of Fat, Feeding, and Egg Laying
To determine the relationships between various 5-HT-regulated
processes,we examined the fat levels of animals defective in var-
ious 5-HT-modulated behaviors. ser-1 and ser-7, which encode
two serotonergic G protein-coupled receptors (GPCRs), are re-
quired for the feeding rate and egg-laying rate increases of
5-HT-treated animals (Hobson et al., 2006; Xiao et al., 2006).
ser-1(ok345) and ser-7(tm1325) mutants displayed wild-type fat
levels and were resistant to 5-HT-induced feeding increase but
remained subject to fat reductionbyexogenous5-HT toanextent
indistinguishable from wild-type animals (Figure 2). Thus, recep-
tors that mediate the serotonergic increase in feeding rate are
distinct from pathways mediating serotonergic fat reduction.
Figure 2. Serotonergic Feeding Increase
Requires ser-1 and ser-7, Whereas Seroto-
nergic Fat Decrease Requires mod-1 and
ser-6
(A) Feeding rates were measured in wild-type con-
trols and the indicated mutants (n = 10) treated
with either vehicle (gray bars) or 5 mM 5-HT (black
bars). Data are expressed as a percentage of vehi-
cle-treated wild-type animals ± SEM. **p < 0.005
versus 5-HT-treated wild-type animals.
(B) Representative images of Nile red-stained ani-
mals treated with vehicle (top row) or 5 mM 5-HT
(bottom row). The anterior end of the animals
shown is oriented toward the left.
(C) The proportion of fat remaining in 5-HT-treated
relative to vehicle-treated animals for each geno-
type (n = 8). Nile red fluorescence intensities
are reported in Table 1. mod-1(ok103) and ser-
6(tm2146) animals retained a significantly greater
proportion of their fat upon 5-HT treatment when
compared to wild-type. Data are expressed as
a percentage of vehicle-treated wild-type animals
± SEM. **p < 0.005.
5-HT modifies the physiological pro-
perties of pharyngeal muscles, leading
to faster contraction-relaxation cycles,
thereby affecting food intake (Niacaris
and Avery, 2003). These cycles are regu-
lated by excitatory acetylcholinergic
(McKay et al., 2004) and inhibitory gluta-
matergic signals (Avery, 1993). eat-2
and eat-18, encoding a pharyngeal mus-
cle-localized nicotinic acetylcholine re-
ceptor and a predicted transmembrane
protein, respectively, and avr-15, encod-
ing a glutamate-gated chloride channel,
are required for nicotinic and glutamater-
gic regulations of pharyngeal muscle, re-
spectively (Dent et al., 1997; McKay et al., 2004). Without 5-HT
treatment, avr-15(ad1051) mutants had wild-type fat content
while eat-2(ad1113) and eat-18(ad1110) animals showed dra-
matically diminished fat levels (Figure S2). The fat levels of all
three mutants were further diminished by 5-HT (Figure S2),
demonstrating that 5-HT exacerbates the reduced fat of feed-
ing-defective animals.
As with feeding, we found that the serotonergic modulation of
egg laying was molecularly independent of serotonergic fat reg-
ulation. In addition to ser-1 and ser-7, egl-30, egl-8, and egl-19,
which encode Gaq, PLC-b, and an L-type calcium channel a
subunit, respectively, are required for serotonergic stimulation
of egg laying (Schafer, 2006). The egg-laying-defective mutants
egl-30(js126), egl-8(n488), and egl-19(ad1015) (Trent et al., 1983)
had nearly wild-type fat and were fully susceptible to the
fat-reducing effects of 5-HT (Figure S2). Similar results were ob-
tained for the egg-laying-constitutive mutants unc-2(e55) and
unc-36(e251), which encode subunits of an L-type voltage-gated
calcium channel required for adaptation to 5-HT, wild-type feed-
ing rate, and movement (Schafer, 2006; Schafer and Kenyon,
1995) (Figure S2), and for animals mutant in ser-4, whichCell Metabolism 7, 533–544, June 2008 ª2008 Elsevier Inc. 535
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(Dempsey et al., 2005) (Figure 2).
Based on sequence similarity to mammalian receptors, the
C. elegans genome encodes at least 16 putative biogenic amine
GPCRs (Bargmann, 1998; Chase and Koelle, 2007) as well as
MOD-1, a 5-HT-gated chloride channel required for the reduc-
tion in locomotor rate when food-deprived animals re-encounter
food (Ranganathan et al., 2000). In addition to serotonergic SER-
1, SER-4, and SER-7 receptors, functional and pharmacological
analyses have placed a subset of the other 13 GPCRs in dopa-
minergic, octopaminergic, and tyraminergic signaling pathways
(Chase and Koelle, 2007) (Table S1). We examined available
loss-of-function mutants in 12 of the 13 putative biogenic amine
GPCRs (Table S1) as well as the serotonergic chloride channel
mod-1 for their potential roles in 5-HT-induced fat reduction.
Only loss-of-functions mutations in mod-1 and the GPCR en-
coded by Y54G2A.35/ser-6 partially abrogated 5-HT-induced
fat reduction (Figure 2). By contrast, egg-laying and feeding rates
of mod-1(ok103) and ser-6(tm2146) animals were indistinguish-
able from wild-type animals with or without 5-HT treatment
(Dempsey et al., 2005) (Figure 2A and data not shown).
Without 5-HT treatment, mod-1(ok103) animals had excess
fat, while fat levels of ser-6(tm2146) mutants were indistinguish-
able from wild-type (Figure 2). We confirmed the excess fat
content of mod-1(ok103) mutants by TLC analysis (Figure S3A).
Relative to their basal levels, wild-type, mod-1(ok103), and
ser-6(tm2146) mutants retained 40%, 70%, and 80% of
their fat upon 5-HT treatment, respectively (Figure 2). Thus,
mod-1 and ser-6 mutants are proportionally less susceptible to
the fat-reducing effects of 5-HT. To evaluate whether the role
ofmod-1 simply reflected increased basal fat content, we exam-
ined the effects of 5-HT on 100 RNAi-induced gene inactiva-
tions that increase fat (Ashrafi et al., 2003). Despite increasing
overall fat content, none of these RNAi treatments blocked the
fat-reducing effects of 5-HT (data not shown). Together, these
findings suggest that the MOD-1 channel and the SER-6
GPCR play specific roles in 5-HT-induced fat reduction.
We found that a GFP reporter fused to the putative promoter
sequence of ser-6 exclusively expressed in a subset of head
and tail neurons (Figure S3B). GFP reporter expression of mod-
1 was previously reported in a few head, ventral cord, and tail
neurons (Ranganathan et al., 2000). Together, these results indi-
cate that serotonergic regulation of fat is mediated through neu-
rally expressed receptors that are distinct from serotonergic
receptors that modulate feeding and egg-laying behaviors.
5-HT-Mediated Fat Loss Is Independent
of Insulin Signaling
As in mammals, insulin signaling is a major neuroendocrine reg-
ulator of energy balance in C. elegans (Nelson and Padgett,
2003). Moreover, several lines of evidence suggest a crosstalk
between C. elegans 5-HT and insulin signaling pathways. For
instance, active signaling through the DAF-2 insulin receptor
inactivates the FOXO transcription factor DAF-16 by inhibiting
its translocation from the cytoplasm to the nucleus (Liang et al.,
2006). Food deprivation, inactivation of insulin signaling, and 5-
HT deficiency promote DAF-16 nuclear localization (Liang et al.,
2006). In turn, exogenous 5-HT shifts DAF-16 to the cytoplasm
in a DAF-2-dependent manner (Liang et al., 2006). Although536 Cell Metabolism 7, 533–544, June 2008 ª2008 Elsevier Inc.daf-2(e1370) mutants have increased fat (Kimura et al., 1997),
we found that these mutants remained susceptible to 5-HT-in-
duced fat reduction (Figure S4). Similarly, daf-16 loss of function
did not alter the fat-reducing effects of 5-HT (Figure S4). Thus, in-
sulin signaling is not required for the fat-reducing effects of 5-HT.
Peripheral Lipid Oxidation Pathways Are Required for
5-HT-Induced Fat Reduction
Our results indicated a dissociation between serotonergic fat
and feeding mechanisms. Fat-reducing effects of 5-HT could
not be attributed to enhanced locomotory activity, as increased
5-HT signaling suppresses C. elegans locomotory rate (Horvitz
et al., 1982). Therefore, we investigated the contribution of met-
abolic pathways by assessing the requirement of each of 100
metabolic genes, encoding various components of fatty acid
b-oxidation, ketogenesis, triacylglycerol synthesis, and fatty
acid elongation and desaturation (Table S2), for 5-HT-mediated
fat reduction. 5-HT-treated animals on control or most test RNAi
clones retained only 35% or less of their basal fat levels (data
not shown). By contrast, each of nine gene inactivations partially
blocked the fat-reducing effect of 5-HT, allowing for 60%–83%
fat retention (Figure 3; Table 1).
Six of these RNAi clones targeted genes predicted to encode
conserved components of mitochondrial and peroxisomal b-ox-
idation pathways. These were an acyl-CoA oxidase (F08A8.4/
aco) and an enoyl-CoA hydratase (F43H9.1/ech), which catalyze
the first two steps of peroxisomal b-oxidation (Salway, 1999);
carnitine palmitoyltransferase-1a (W01A11.5/cpt-1a), required
for transport of fatty acyl-CoAs into mitochondria; and a me-
dium-chain acyl-CoA dehydrogenase (T08G2.3/mcad), a 30-
hydroxyacyl-CoA dehydrogenase (F01G4.2/30OH-acd), and an
acetoacetyl-CoA thiolase (T02G5.8/kat-1), all of which are mito-
chondrial components of fatty acyl-CoA breakdown (Salway,
1999) (Figure S5A). Additionally, this screen identified a fatty
acid binding protein (EEED8.2/fabp) and two acyl-CoA syn-
thases, F37C12.7/acs-4 and Y76A2B.3/acs-5, homologous to
mammalian acs-4 and acs-5, respectively. ACS proteins cata-
lyze the attachment of coenzyme A to fatty acids, activating
them for breakdown or synthesis, while FABPs facilitate intracel-
lular transport of fatty acids (Salway, 1999). Among these nine
genes, we selected Y76A2B.3/acs-5 and confirmed by Sudan
black staining that this gene inactivation suppressed 5-HT-in-
duced fat reduction (Figures S6A–S6F). Together, these results
suggest that the flux of stored fats through b-oxidation pathways
partially accounts for the fat reduction in 5-HT-treated animals.
For each of the nine genes identified, the C. elegans genome
encodes multiple family members, all of which were included in
our RNAi screen (Table S2). While we do not know the efficacy
of RNAi for all clones tested, our findings suggest that the fat-
reducing effects of 5-HT are dependent on specific family mem-
bers. In support of this assertion, we found that RNAi inactiva-
tions/loss-of-function mutations in some of the other family
members caused dramatic increases in fat content without
blocking the fat-reducing effects of 5-HT (data not shown).
To determine sites of function of these metabolic genes, we
generated reporter fusions utilizing 2–3 kb of each gene’s pre-
dicted promoter sequence fused to GFP. These transcriptional
reporters primarily showed expression in the intestine and in
the skin-like epidermis, two major sites of C. elegans fat storage
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vious report of T02G5.8/kat-1 thiolase expression in intestinal
andmuscle tissues (Mak et al., 2006). The predicted peroxisomal
F08A8.4/aco and F43H9.1/ech were most strongly expressed in
intestinal cells, while the predicted mitochondrial b-oxidation
genesshowedexpression inboth theepidermis and the intestine.
To further evaluate the roles of the nine metabolic genes, we
assessed their transcriptional responses to 5-HT by real-time
qPCR. 5-HT treatment elicited transcriptional upregulation in
several of the nine genes, including 4- to 6-fold increases in
Y76A2B.3/acs-5 and T08G2.3/mcad (Figure 4I). These findings
indicate that neural 5-HT signaling initiates a signaling cascade
to ultimately promote fat utilization via select lipid oxidation path-
ways in the periphery.
5-HT Treatment Increases Energy Expenditure Fueled
by Fat Oxidation
One explanation for increased activation of lipid oxidation path-
ways may be an increased demand for energy expenditure in 5-
HT-treated animals. To assess this possibility, we designed and
Figure 3. b-Oxidation Genes Are Required
for the Fat-Reducing Effect of 5-HT
(A) Representative images of Nile red-stained ani-
mals treated with the indicated RNAi clones ex-
posed to either vehicle (top rows) or 5-HT (bottom
rows). The anterior end of the animals shown is ori-
ented toward the left.
(B) Data are expressed as the proportion of fat re-
maining in 5-HT-treated relative to vehicle-treated
animals on HT115 bacteria exposed to each indi-
cated RNAi ± SEM (n = 8). Nile red fluorescence in-
tensities are reported in Table 1. **p < 0.005 versus
wild-type on vector control RNAi.
validated an assay for oxygen consump-
tion as a measure of total-body energy
expenditure (Figures S5B–S5D). Oxygen
consumption in 5-HT-treated animals
was increased by 15% relative to
vehicle-treated animals, while it was
reduced by 30% in 5-HT-deficient
tph-1(mg280)mutants compared to wild-
type animals (Figure 5A; Figure S5D).
Without 5-HT, animals exposed to con-
trol or each of the nine metabolic RNAi
clones displayed oxygen consumption
rates similar to wild-type animals (Fig-
ure 5A). By contrast, inactivations of
each of F37C12.7/acs-4, Y76A2B.3/acs-
5, W01A11.5/cpt-1a, and F08A8.4/aco
fully suppressed the increased oxygen
consumption of 5-HT-treated animals
(Figure 5A). While inactivations of each of
EEED8.2/fabp, T08G2.3/mcad, F43H9.1/
ech, F01G4.2/3-hacd, and T02G5.8/
kat-1 partially blocked 5-HT-induced fat
reduction, they had no effect on the
increased oxygen consumption rates of 5-HT-treated animals
(Figure 3; Figure 5A).
Given that ACS proteins activate fatty acids into acyl-CoA moi-
eties that are subsequently imported into peroxisomes and mito-
chondria by actions of ACO andCPT-1a proteins (see Figure S5A)
(Salway, 1999), our findings suggested that flux of fats through
b-oxidation pathways is a principal mechanism for meeting in-
creased energy expenditure of 5-HT-treated animals. However,
once fatty acyl-CoAs gain entry into peroxisomal or mitochondrial
oxidation pathways, blockage of their breakdown uncouples fat
reduction and energy expenditure, perhaps through activation of
compensatory mechanisms of ATP generation through glycolysis
or protein degradation. Indeed, pharmacological or genetic
inactivations of mammalian mitochondrial fatty-acid b-oxidation
pathwayselicit suchcompensatory increases inglucoseoxidation
(Adhikari et al., 2007) andoxygenconsumption (Hutter etal., 1985).
Metabolic Intermediates Regulate Feeding Rate
Inactivations of either F08A8.4/aco or W01A11.5/cpt-1a not only
abrogated 5-HT-induced increase in oxygen consumption butCell Metabolism 7, 533–544, June 2008 ª2008 Elsevier Inc. 537
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Subcellular Localization Tissue LocalizationVehicle 5-HT
wild-type (N2) 100.0 ± 6.0 42.3 ± 5.1
F59C12.2 ser-1(ok345) 95.2 ± 12.1 44.8 ± 5.0 plasma membrane pharyngeal muscle,
vulvaa
C09B7.1 ser-7(tm1325) 103.3 ± 9.0 45.6 ± 9.3 plasma membrane interneuronsa
Y22D7AR.13 ser-4(ok512) 110.0 ± 9.9 45.6 ± 8.9 plasma membrane pharyngeal neurons,
vulvaa
K06C4.6 mod-1(ok103) 128.1 ± 11.4 86.8 ± 4.5 plasma membrane interneuronsb
Y54G2A.35 ser-6(tm2146) 98.0 ± 6.9 70.0 ± 3.1 plasma membrane sensory neurons,
interneuronse
R13H8.1 daf-16(mgDf47) 90.5 ± 4.1 30.6 ± 4.8 cytoplasmic/nuclearc ubiquitousc
vector RNAi 100.0 ± 7.6 34.0 ± 3.7
W01A11.5 carnitine palmitoyltransferase-1a 138.3 ± 8.3 93.7 ± 7.8 mitochondriald epidermise
F08A8.4 acyl-CoA oxidase 115.6 ± 7.5 68.5 ± 6.0 peroxisomald intestinee
EEED8.2 fatty acid binding protein 94.5 ± 9.2 66.3 ± 6.9 cytoplasmicd epidermis, intestinee
F37C12.7 acyl-CoA synthase-4 99.5 ± 5.5 82.5 ± 5.0 – intestine, pharyngeal
musclee
Y76A2B.3 acyl-CoA synthase-5 113.3 ± 8.1 85.4 ± 6.4 mitochondriald epidermis, intestinee
T08G2.3 mitochondrial acyl-CoA
dehydrogenase
113.0 ± 5.6 81.7 ± 6.6 mitochondriald epidermis, intestinee
F43H9.1 enoyl-CoA hydratase 103.2 ± 5.6 78.5 ± 4.4 peroxisomald intestinee
F01G4.2 30-hydroxyacyl-CoA
dehydrogenase
90.2 ± 9.4 58.9 ± 2.9 mitochondriald epidermis, intestinee
T02G5.8 acetoacetyl-CoA thiolase (kat-1) 158.3 ± 7.8 112.2 ± 8.7 mitochondrialf intestine, body
wall musclef
Wild-type and mutant strains at top were grown on OP50 bacteria. Wild-type (N2) animals at bottom were grown on the RNAi clones produced by
HT115 bacteria. We observed that 5-HT was approximately 10% more efficacious in reducing the intensity of Nile red staining in HT115 bacteria
compared to OP50. All comparisons were made to the appropriate controls. All values are means ± SEM. For each condition, n = 8 animals.
a Hobson et al. (2006).
b Ranganathan et al. (2000); Zhang et al. (2005).
c Ogg et al. (1997).
d Predicted using TargetP and PSORT as described previously (Van Gilst et al., 2005).
e This study.
fMak et al. (2006).reduced oxygen consumption below the levels observed when
animals were treated with RNAi alone (Figure 5A). In themamma-
lian hypothalamus, buildup of long-chain fatty acyl-CoAs and
inactivation of CPT-1a, which leads to acyl-CoA accumulation,
inhibit feeding (Lam et al., 2005). Since accumulation of acyl-
CoA moieties correlates with plentiful energy supplies, their
effects on food intake have been interpreted as homeostatic
satiety signals (Lam et al., 2005). Similarly, we found that inacti-
vation of F08A8.4/aco orW01A11.5/cpt-1a, but none of the other
metabolic genes, abrogated the increased feeding rate of 5-HT-
treated animals (Figure 5B).
Given the mammalian precedents, we hypothesized that the
normalized feeding rates of 5-HT-treated animals in which either
F08A8.4/aco or W01A11.5/cpt-1a had been inactivated re-
flected accumulation of acyl-CoA moieties. Direct biochemical
measurements of acyl-CoA moieties from C. elegans extracts
are challenging since these moieties are produced in small
quantities and in only a subset of cells. To provide evidence
for our hypothesis, we tested whether excess dietary fatty acids538 Cell Metabolism 7, 533–544, June 2008 ª2008 Elsevier Inc.affected the feeding rate of well-fed wild-type animals. Expo-
sure to 1 mM oleic acid (C18:1n-9) for 30 min resulted in
20% reduction in feeding rate (Figure 5C) but no other obvious
concomitant behavioral and morphological changes. This re-
duction in feeding was abrogated by a 30 min pretreatment
with 1 nM triacsin C, a pharmacological inhibitor of ACS en-
zymes, and also by RNAi-mediated inactivation of either
F37C12.7/acs-4 or Y76A2B.3/acs-5 (Figure 5C). At the indicated
concentration, triacsin C administration alone had no effects on
feeding rate (Figure 5C), supporting the notion that conversion
of dietary oleic acid to its CoA derivatives causes decreased
feeding rate.
These results reveal that the simultaneous mobilization of
stored fatty acids via serotonergic signals and the prevention
of their breakdown via inactivation of genes that function as
gatekeepers of b-oxidation elicit a homeostatic reduction in
feeding rate. Thus, as in mammals, acyl-CoA moieties or their
metabolic derivates likely function as feeding regulatory signals
in C. elegans.
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Peripheral b-Oxidation Pathways
To determine pathway relationships between neural and periph-
eral components required for serotonergic fat reduction, we
performed pairwise epistasis analyses between several path-
way components. Upon 5-HT treatment, mod-1(ok103);ser-
6(tm2146) double mutants retained a greater proportion of their
fat compared to either single mutant alone (Figures 6A and 6B).
Moreover, RNAi inactivation of Y76A2B.3/acs-5 and F08A8.4/
aco in ser-6(tm2146) did not alter basal fat levels or fat retention
of these mutants when treated with 5-HT. By contrast, inactiva-
tions of either Y76A2B.3/acs-5 or F08A8.4/aco improved the
proportion of fat retained in 5-HT-treatedmod-1mutants without
altering the fat content of untreated animals (Figure 6C; TableS3).
These findings suggested thatmod-1 andperipherally expressed
metabolic genes define a pathway of serotonergic fat regulation
that is mechanistically distinct from that defined by ser-6.
We examined the transcriptional profiles of the nine peripheral
lipid oxidation genes by real-time qPCR in mod-1(ok103) and
ser-6(tm2146)mutants with or without exogenous 5-HT. Inactiva-
tionofmod-1didnot alter theexpression levelsof thesemetabolic
genes in the absence of 5-HT treatment but abrogated increased
Figure 4. Expression Patterns of b-Oxida-
tion Genes
(A–H)Representative imagesof transgenic animals
expressing GFP reporter fusions for promoters of
the indicated genes. Inset panels show corre-
sponding differential interference contrast images.
(I) Change in transcript levels of the indicated met-
abolic genes upon 5-HT treatment in wild-type an-
imals as determined by real-time qPCR. Data are
reported as the average of two independent
cDNA preparations ± SEM.
transcriptional changes elicited by 5-HT
treatment (Figure 4I; Figure S6G). In the
absence of 5-HT, inactivation of ser-6 re-
sulted in transcriptional downregulation
of a subset of peripheral lipid oxidation
genes (Figure S6G). Although 5-HT treat-
ment of ser-6 mutants caused transcrip-
tional upregulation of peripheral lipid oxi-
dation genes, expression levels of these
genes remained below those observed in
5-HT-treated wild-type animals, and in
some cases even below those of un-
treated animals (Figure S6G). These find-
ings further support the notion that ser-6
and mod-1 define distinct mechanisms
mediating serotonergic fat regulation.
Together, these analyses suggest that
peripheral lipid oxidation genes remain
effectively inactivated in ser-6 mutants
such that their inactivation by RNAi
does not further improve fat retention in
5-HT-treated ser-6 animals. By contrast,
since these genes display wild-type basal
expression levels in mod-1 animals, they
contribute to 5-HT-induced fat reduction because mod-1 is
required for 5-HT-induced upregulation of these genes.
DISCUSSION
In this report, we delineate agenetic andmolecular framework for
C. elegans serotonergic fat and feeding regulation. Our findings
suggest that serotonergic regulation of fat is not a consequence
of other 5-HT-regulated behaviors but rather a distinct metabolic
response initiated in the nervous system.We identified the 5-HT-
gated chloride channel encoded by mod-1 and the GPCR en-
coded by ser-6 as components of signaling mechanisms linking
neural 5-HT to peripheral mobilization of fat stores. This feed-
ing-independent neural fat regulatory pathway ultimately causes
fat reduction by promoting lipid oxidation via select b-oxidation
genes in the periphery. In turn, we found evidence thatC. elegans
modulate their feeding rate in response to peripheral accumula-
tion of acyl-CoAs or their derivates, which are postulated to be
gauges of fuel availability in mammals (Lam et al., 2005). Thus,
theC. elegans nervous system can regulate fat content indepen-
dent of feeding behavior, but this behavior is subject to homeo-
static regulation by internal cues of energy availability.Cell Metabolism 7, 533–544, June 2008 ª2008 Elsevier Inc. 539
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sociated with fat loss while reduced signaling is associated with
fat accumulation. Unlike mammals, serotonergic effects on
C. elegans fat are inversely correlated with its effects on feeding.
Interestingly, several lines of evidence from mammalian stud-
ies suggest that changes in feeding alone cannot account for the
observed effects of 5-HT deficiency or excess on fat content. First,
while 5-HT2C receptor mutant mice are chronically hyperphagic
and hyperactive, they do not develop obesity until 5–6 months of
age (Nonogaki et al., 2003). This obesity develops without a fur-
ther increase in hyperphagia and despite increased hyperac-
tivity. Second, in both rodents and humans, chronic administra-
tion of serotonergic compounds promotes fat reduction that can
bemaintained for extended periods of time as long as drug treat-
ment is continued; however, the reported feeding reduction,
while significant upon initiation of drug treatment, is only tran-
sient and quickly rebounds to pretreatment levels despite
continued drug treatment and maintenance of reduced weight
Figure 5. Effects of b-Oxidation Genes on
Oxygen Consumption and Feeding Rate
(A) Oxygen consumption measurements (n = 800
animals per condition) with or without 5-HT for
vector and RNAi-treated animals. Data are
expressed as a percentage of wild-type vehicle-
treated animals ± SEM. **p < 0.005 versus 5-HT-
treated animals on vector control RNAi. In (A)
and (B), gray bars represent vehicle-treated
animals and black bars represent 5-HT-treated
animals.
(B) Effects of 5-HT on feeding rate (n = 10 animals
per condition). Data are expressed as a percent-
age of wild-type vehicle-treated animals ± SEM.
**p < 0.005 versus 5-HT-treated animals on vector
control RNAi.
(C) Effects of dietary oleic acid, triacsin C, and in-
activations of acs genes on feeding rate. Data are
expressed as a percentage of vehicle-treated
animals ± SEM. **p < 0.005 when comparing the
indicated treatments.
(Fernstrom and Choi, 2008; Vickers
et al., 2000). Upon discontinuation of
drug treatment, weight gain resumes
without further increases in feeding (Choi
et al., 2002). Third, the central melanocor-
tin pathway, a principal regulator of fat
and feeding (Ellacott and Cone, 2006),
has been shown to mediate the anorectic
effects of increased central 5-HT signal-
ing (Heisler et al., 2003). Selective expres-
sion of the melanocortin-4 receptor
(MC4R) in subpopulations of neurons in
mc4r null mice revealed that the effect of
MC4R on food intake is dissociable from
its effect on energy expenditure (Baltha-
sar et al., 2005). Finally, similar to C. ele-
gans, changes in central serotonergic sig-
naling also elicit changes in energy
expenditure in both rodents and humans
(Even and Nicolaidis, 1986; Lam and Heisler, 2007; Le Feuvre
et al., 1991; Rothwell and Stock, 1987). Thus, in mammals, as
in C. elegans, 5-HT regulation of fat may be largely independent
of feeding, highlighting the ancient origins of 5-HT as a regulator
of energy balance and that the basic organization of central ver-
tebrate serotonergic nervous systemswas already established in
their invertebrate ancestors (Hay-Schmidt, 2000).
Since C. elegans directly match their feeding rates to increas-
ing and decreasing food concentrations, 5-HT-induced effects
on fat and feeding in C. elegans are consistent with the role of
this neuromodulator as a sensory gauge of nutrient availability.
As in animals preparing for the hibernating dauer state, which is
characterized by buildup of fat reservoirs, the excess fat of 5-
HT-deficient animals is a responseconsistentwith theperception
of diminishing food availability and a shift in metabolism that fa-
vors energy conservation and directs nutrients into fat reservoirs.
Accordingly, 5-HT-induced fat reduction is consistent with the
reactivation of energy-utilizing pathways that accompany the540 Cell Metabolism 7, 533–544, June 2008 ª2008 Elsevier Inc.
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Moreover, we found that 5-HT treatment caused increased feed-
ing rates even when animals were already well fed. Since C. ele-
gans can distinguish food quality in a 5-HT-dependent manner
(Shtonda and Avery, 2006) and since their feeding rate can be
modulated based on previous experience of starvation (Avery
andHorvitz, 1990),wepostulate that, rather than serving asa sim-
ple switch indicating food presence, 5-HT signaling functions as
a sophisticated gauge whose relative abundance could reflect
various food-related contexts and experiences. The full range of
environmental and physiological signals that could operate
through 5-HT signaling are not yet known.
Given the contributions of the serotonergic pathway to energy
balance across phylogeny, we speculate that human counter-
parts of feeding-independent fat regulatory genes identified in
our study may similarly regulate energy balance.
EXPERIMENTAL PROCEDURES
C. elegans Maintenance and Strain Constructions
Nematodes were cultured on OP50 bacterial lawns on nematode growth me-
dium (NGM) plates at 20C. N2 Bristol was used as the wild-type reference
Figure 6. ser-6 and mod-1 Mediate Seroto-
nergic Fat Regulation through Distinct
Mechanisms
(A) Representative images of Nile red-stained ani-
mals exposed to either vehicle (top row) or 5-HT
(bottom row). The anterior end of the animals
shown is oriented toward the left.
(B) mod-1(ok103);ser-6(tm2146) double mutants
block serotonergic fat reduction to a greater de-
gree than either single mutant alone. Data are ex-
pressed as a percentage of vehicle-treated wild-
type animals ± SEM. n = 8; *p < 0.05. Nile red inten-
sity measurements used to generate the graphs in
(B) and (C) are reported in Table S3.
(C) RNAi inactivations of Y76A2B.3/acs-5 and
F08A8.4/aco in mod-1(ok103) but not ser-
6(tm2146) animals cause a further block in seroto-
nergic fat reduction. Data are expressed as a per-
centage of vehicle-treated animals ± SEM. n = 8;
*p < 0.05.
strain. The following outcrossed strains were ana-




IV, mod-1(ok103)V, avr-15(ad1051)V, egl-8
(n488)V, ser-1(ok345)X, ser-7(tm1325)X, and unc-
2(e55)X. GPCR mutants are listed in Table S2.
When generating double mutants, desired geno-
types arising from a cross were determined by
PCR analysis. For all experiments, strains were
synchronized by hypochlorite treatment of gravid
adults.
5-HT, Fluoxetine, Oleic Acid, and
Triacsin C Treatment
5-HT hydrochloride powder (Sigma) was dissolved
in 0.1MHCl to a concentration of 0.1M and added
to NGM plates seeded with either OP50 or vector
RNAi (HT115) to a final plate concentration of 5 mM, or 10 mM (only when
noted). Plates were allowed to equilibrate overnight and used the next day.
For vehicle-treated controls, 0.1 M HCl was added to plates to a final concen-
tration of 5mM. This HCl treatment did not affect growth, viability, or fecundity.
Synchronized L1-stage animals were plated on vehicle- or 5-HT-treated
plates, and fat content, feeding rate, and oxygen consumption were measured
in young adults. We noted that 5-HT was more efficacious on HT115 bacteria
(60%–70% fat reduction) compared to OP50 bacteria (50%–60% fat reduc-
tion). Fluoxetine (Sigma) was used at a final concentration of 20 mg/ml. Oleic
acid (Sigma) was solubilized in 45% (w/v in dH2O) 2-hydroxypropyl-b-cyclo-
dextrin to 1M and then added to NGM/OP50 plates with PBS to a final concen-
tration of 1 mM. Triacsin C (Sigma) was solubilized in DMSO and used at 1 nM
concentration on NGM/OP50 plates. In both cases, L4-stage animals were
transferred to plates containing the appropriate vehicle or drug for the desig-
nated time period before counting feeding rate. Chronic treatment with triacsin
C (1 mM) resulted in larval arrest.
Nile Red Staining, Image Acquisition, and Quantitation
Nile red staining of nematodes was conducted as described previously (Ash-
rafi et al., 2003). For routine examination and screening, Nile red fluorescence
was visualized using a Zeiss SV11 M2-Bio microscope equipped with a Texas
red filter (596 nm excitation, 613 nm emission). For image analyses and quan-
titation, images were captured using a digital CCD camera (Hamamatsu
C4742-95-12ER) attached to a Zeiss Axioplan II microscope. All Nile red im-
ages were acquired using identical settings and exposure times to allow directCell Metabolism 7, 533–544, June 2008 ª2008 Elsevier Inc. 541
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intensities were linear with exposure time and below saturation. Reported
Nile red intensities of the first two pairs of intestinal cells were quantified using
ImageJ software (NIH). This region accounts for most of the variation seen
between all tested strains and conditions. For all Nile red quantifications,
8–10 worms of each genotype were randomly selected under the dissecting
microscope (without fluorescence) and imaged as described. Each experi-
ment was repeated at least three times, and all reported results were consis-
tent in all repeats.
RNAi
HT115 bacteria containing each RNAi vector (see Table S1) were tested as de-
scribed previously (Ashrafi et al., 2003) with the following modification: after
overnight growth, bacteria were pelleted and resuspended to 53 concentra-
tion, 0.1 ml of which was used for seeding each well of a 12-well plate contain-
ing 4 ml NGM agar, 6 mM IPTG, and 25 mg/ml carbenicillin. Next, Nile red and
5-HT or HCl vehicle were added on top of each well, and the plates were
allowed to equilibrate overnight. Twenty to thirty synchronized wild-type or
mutant L1 animals were placed per well and incubated at 20C to adulthood.
Nile red assessment was performed on gravid adult animals. For each RNAi
experiment, HT115 (vector alone) and OP50 control wells were also included.
All 5-HT suppression phenotypes were confirmed by multiple (5–10) additional
rounds of testing on the selected clones, whose identities were confirmed by
DNA sequencing. At the time of scoring Nile red phenotypes, the identities of
the target RNAi clones were unknown.
Sudan Black B staining
Staining was performed as described previously (Kimura et al., 1997) with the
following modification: 5-HT-treated animals were marked with FITC, mixed in
with vehicle-treated animals, and stained in the same tube tominimize staining
variation. Fat decrease in 5-HT-treated animals was scored first and then
matched to genotype and conditions using FITC staining.
Measurement of Triacylglycerides
Synchronized L4-stage animals were washed off 6 cmplates using 0.9%NaCl,
centrifuged gently to pellet worms, and washed twice in 0.9% NaCl. After in-
cubation for 20 min at room temperature, nematodes were pelleted again by
centrifugation and resuspended in 500 ml H2O. One hundred microliters was
removed for protein determination, and total cellular lipids were extracted
from 400 ml nematode suspension as described previously (Bligh and Dyer,
1959). For quantification of triacylglycerides, extracts were applied to Silica
Gel 60 plates (Merck) with the aid of a sample applicator (Linomat IV; CAMAG,
Muttenz, Switzerland), and chromatograms were developed using the solvent
system hexane/diethyl ether/acetic acid (70:30:1, v/v). Triacylglycerides were
visualized by postchromatographic staining by dipping plates for 6 s into a de-
veloping reagent consisting of 0.63 g of MnCl2, 60 ml of water, 60 ml of meth-
anol, and 4 ml of concentrated sulfuric acid, briefly dried, and heated at 100C
for 30 min. Quantification of triacylglycerides was carried out by densitometric
scanning at 400 nm using a Typhoon Trio variable-mode imager (Amersham
Biosciences) with triolein (Sigma) as a standard. The worm suspension
removed for protein determination (100 ml) was adjusted to a final volume of
400 ml with H2O and sonicated twice for 30 s (Branson, intensity level 20).
Tris-HCl and SDS were added to the extracts to a final concentration of 40
mMand 0.1%, respectively, and incubated for 1 hr at 4C. The protein concen-
tration was determined using the Qubit assay system according to the manu-
facturer (Invitrogen). All measurements were performed in triplicate per strain,
and each strain was subject to at least two independent rounds of triglyceride
measurement.
Feeding Rate Assay
Feeding rates were measured in gravid adults raised at 20C on OP50 or RNAi
bacteria. All measurements were performed at room temperature (22C).
Feeding rate was measured for each animal by counting the rhythmic contrac-
tions of the pharyngeal bulb over a 10 s period under a Zeiss M2-Bio micro-
scope. For each genotype, ten animals were counted per condition and the
experiment was repeated at least three times.542 Cell Metabolism 7, 533–544, June 2008 ª2008 Elsevier Inc.Oxygen Consumption Assay
Oxygen consumptionwasmeasured in gravid adult animals washed off culture
plates with S basal and then washed once more with S basal. For each geno-
type, 200 animals were deposited in a single well of a 96-well plate containing
a biosensor film whose fluorescence intensity increases in proportion to the
amount of oxygen consumed (BD Biosciences). Oxygen consumption was
measured over a 3 hr period, which we determined empirically to be required
for the biosensor film to reach equilibrium. The data reported are endpoint
measurements since they accurately reflect changes in oxygen concentration
of the samples rather than changes due to equilibration of the biosensor film.
Within a single experiment, each genotype was measured in quadruplicate,
and each experiment was repeated three to five times. Fluorescence (485 nm
excitation, 590 nm emission with cutoff at 550 nm) was measured using a
Molecular Devices FlexStation. The mitochondrial uncoupler rotenone
(Salway, 1999) (Sigma) decreased oxygen consumption in a dose-dependent
manner and was used to validate the assay.
Real-Time qPCR
Total RNA extraction, cDNA preparation, and real-time qPCR were performed
as described previously (Van Gilst et al., 2005). Primer sequences used for the
genes tested are listed in Table S4. The data were standardized to GAPDH,
which did not vary by more than one cycle threshold value in all conditions
tested. For all conditions tested, two independent rounds of nematode growth
followed by multiple cDNA preparations from each growth were performed to
ensure the accuracy and consistency of the observed changes.
Generation of GFP Reporter Fusion Constructs
and Transgenic Animals
GFP reporter constructs were generated using Gateway Technology (Invitro-
gen) reagents. The promoters for W01A11.5, F37C12.7, F43H9.1, F01G4.2,
T02G5.8, and EEED8.2 were obtained from Open Biosystems. These pro-
moters included an approximately 2 kb region upstream of the start site for
each corresponding gene. For Y54G2A.35, Y76A2B.3, and T25G12.5, we
PCR amplified 2–3 kb upstream of each gene’s start site, typically where
the next upstream coding sequence was located. We tested two promoters
for F08A8.4, a short 0.5 kb promoter and a longer 2 kb promoter beginning
within the penultimate exon of the upstream gene, both of which gave identical
results. Promoters were cloned into the Gateway vector pDONR-P4-P1R (a
gift from M. Vidal) and sequenced to confirm their identity. In all cases, pro-
moters were placed upstream of a GFP reporter with an unc-54 30UTR.
Purified plasmids were injected into the gonads of wild-type N2 animals to
obtain stable transgenic lines. At least ten independent transgenic lines were
generated for each construct, and 20–30 animals from three to five lines
were examined in detail to confirm the consistency of expression patterns. Im-
ageswere captured using a digital CCD camera (HamamatsuC4742-95-12ER)
attached to a Zeiss Axioplan II microscope equipped with a FITC/GFP filter
(500–515 nm emission).
Statistical Analyses
Student’s t test was used to determine the significance of the data for feeding
rate, fat content, and oxygen consumption assays.
SUPPLEMENTAL DATA
Supplemental Data include six figures and four tables and can be found
with this article online at http://www.cellmetabolism.org/cgi/content/full/7/6/
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